Gene: FLNB

2317
ABP-278|ABP-280|AOI|FH1|FLN-B|FLN1L|LRS1|SCT|TABP|TAP
filamin B
protein-coding
3p14.3
Ensembl:ENSG00000136068 MIM:603381 Vega:OTTHUMG00000159158 UniprotKB:O75369
NG_012801.1
SNP Mapped
4   ANCO-SNPs
AD
0   
NA (AD)  NA (ND)   (Frontal_Cortex)
8.886e-1 (AD)  1.351e-1 (ND)

ANCO-SNPs

SNP ID Position Alleles Trait Variation Type
rs4681795chr3:58150702 (GRCh38.p7)T>Calcohol dependenceSNV(Single Nucleotide Variation)
rs2362904chr3:58126761 (GRCh38.p7)C>Talcohol dependenceSNV(Single Nucleotide Variation)
rs4681800chr3:58124021 (GRCh38.p7)T>Aalcohol dependenceSNV(Single Nucleotide Variation)
rs7615893chr3:58112717 (GRCh38.p7)T>Calcohol dependenceSNV(Single Nucleotide Variation)

DNA Methylation

Probe Locus(GRCh37) Gene Region p-val Trait PubMed ID
cg13142374chr3:58026831FLNB4.200e-10Smoking27651444

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
CDK60.809
WNK10.798
KIF13B0.796
GAB20.788
PDE8A0.773
ARHGEF370.759
SMARCC10.756
MICALL10.755
CDK190.752
TMCC30.75

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
WNT7B-0.367
OR4F29-0.367
CALB2-0.341
ARSF-0.332
CHRNA2-0.331
SLC29A4-0.315
CUX2-0.313
SOX1-0.311
CRH-0.307
POU3F1-0.3

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C0264861,2,5,6-dibenzanthracene"1,2,5,6-dibenzanthracene results in increased expression of FLNB mRNA"26377693
C1111182',3,3',4',5-pentachloro-4-hydroxybiphenyl"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of FLNB mRNA"19114083
C0235142,6-dinitrotoluene"2,6-dinitrotoluene affects the expression of FLNB mRNA"21346803
C0230353,4,5,3',4'-pentachlorobiphenyl"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of FLNB mRNA"19692669
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLNB mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLNB mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLNB mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLNB mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLNB mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLNB mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLNB mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLNB mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLNB mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLNB mRNA"27188386
D000082AcetaminophenAcetaminophen results in decreased expression of FLNB mRNA21420995
D000082AcetaminophenAcetaminophen results in increased expression of FLNB mRNA29067470
D000082AcetaminophenAcetaminophen affects the expression of FLNB mRNA17562736
D016604Aflatoxin B1Aflatoxin B1 results in decreased expression of FLNB mRNA19770486
D018501Antirheumatic AgentsAntirheumatic Agents results in decreased expression of FLNB mRNA24449571
D001151ArsenicArsenic affects the methylation of FLNB gene25304211
C006632arsenic trioxidearsenic trioxide results in decreased expression of FLNB protein25419056
C006632arsenic trioxideFLNB protein results in decreased susceptibility to arsenic trioxide20707922
C015001arsenitearsenite results in increased expression of FLNB mRNA18191166
C006703benzo(b)fluoranthenebenzo(b)fluoranthene results in increased expression of FLNB mRNA26377693
C022921benzo(k)fluoranthenebenzo(k)fluoranthene results in decreased expression of FLNB mRNA21635667
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of FLNB mRNA19770486
D004958EstradiolEstradiol results in decreased expression of FLNB mRNA20068009
C543008bis(4-hydroxyphenyl)sulfone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of FLNB mRNA28628672
C006780bisphenol A[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FLNB mRNA28628672
C006780bisphenol Abisphenol A results in increased expression of FLNB mRNA23704952|2606340
C006780bisphenol Abisphenol A results in increased expression of FLNB mRNA25181051
C006780bisphenol Abisphenol A results in increased methylation of FLNB gene28505145
C000611646bisphenol F[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FLNB mRNA28628672
D020122tert-Butylhydroperoxidetert-Butylhydroperoxide results in increased expression of FLNB mRNA15336504
C584509C646 compoundC646 compound results in increased expression of FLNB mRNA26191083
D002104CadmiumCadmium results in increased expression of FLNB mRNA24376830
D002104CadmiumCadmium results in increased oxidation of FLNB protein24077948
D019256Cadmium ChlorideCadmium Chloride results in decreased methylation of FLNB promoter22457795
D002220CarbamazepineCarbamazepine affects the expression of FLNB mRNA25979313
D002251Carbon TetrachlorideCarbon Tetrachloride results in increased expression of FLNB mRNA17484886
C100187chloropicrinchloropicrin results in decreased expression of FLNB mRNA26352163|2847649
D002794Choline[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FLNB gene20938992
C039671ciglitazone[ciglitazone binds to PPARG protein alternative form] which results in increased expression of FLNB mRNA16197558
C018021cobaltous chloridecobaltous chloride results in decreased expression of FLNB mRNA19320972
C018021cobaltous chloridecobaltous chloride results in increased expression of FLNB mRNA22941251
D003300Copper[NSC 689534 binds to Copper] which results in increased expression of FLNB mRNA20971185
D003471CuprizoneCuprizone results in increased expression of FLNB mRNA26577399
D016572CyclosporineCyclosporine results in increased expression of FLNB mRNA20106945
C017180decamethrindecamethrin results in increased expression of FLNB mRNA19017407
C014347decitabinedecitabine results in decreased expression of FLNB mRNA27915011
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of FLNB mRNA28628672
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FLNB mRNA28628672
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FLNB mRNA28628672
C041517dibenzo(a,l)pyrene"dibenzo(a,l)pyrene results in decreased expression of FLNB mRNA"25908611
D002945CisplatinCisplatin results in decreased expression of FLNB mRNA19561079|2759478
C000944dicrotophosdicrotophos results in increased expression of FLNB mRNA28302478
D004041Dietary FatsDietary Fats results in increased expression of FLNB mRNA18042831
C118739entinostatentinostat results in increased expression of FLNB mRNA26272509|2718838
C118739entinostat"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLNB mRNA"27188386
D004791Enzyme Inhibitors[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of FLNB protein23301498
D000431EthanolEthanol results in increased expression of FLNB mRNA28986285
C540355fenamidonefenamidone results in increased expression of FLNB mRNA27029645
D018120FinasterideFinasteride results in increased expression of FLNB mRNA24136188
D005485FlutamideFlutamide results in decreased expression of FLNB mRNA24793618
D005492Folic Acid[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FLNB gene20938992
C069837fullerene C60fullerene C60 results in increased expression of FLNB mRNA19167457
C039281furanfuran results in increased methylation of FLNB gene22079235
D019833GenisteinGenistein results in increased methylation of FLNB gene28505145
D017313FenretinideFenretinide results in increased expression of FLNB mRNA28973697
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of FLNB mRNA28628672
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FLNB mRNA28628672
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FLNB mRNA28628672
D015759Ionomycin[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of FLNB mRNA25613284
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of FLNB mRNA28628672
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FLNB mRNA28628672
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FLNB mRNA28628672
C410337K 7174K 7174 results in increased expression of FLNB mRNA24086573
C042720mercuric bromidemercuric bromide results in increased expression of FLNB mRNA26272509
C042720mercuric bromide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLNB mRNA"27188386
D008628MercuryMercury results in increased expression of FLNB mRNA19937285
D008694MethamphetamineMethamphetamine results in increased expression of FLNB mRNA26307267
D008715Methionine[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FLNB gene20938992
C004925methylmercuric chloridemethylmercuric chloride results in increased expression of FLNB mRNA28001369
D008767Methylmercury CompoundsMethylmercury Compounds affects the expression of FLNB mRNA21664453
D008767Methylmercury CompoundsMethylmercury Compounds affects the expression of FLNB mRNA21664453
D008741Methyl MethanesulfonateMethyl Methanesulfonate results in increased expression of FLNB mRNA26011545
D018817N-Methyl-3,4-methylenedioxyamphetamine"N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of FLNB mRNA"26251327
C583365N-(2-(1,1'-bicyclopropyl)-2-ylphenyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide"N-(2-(1,1'-bicyclopropyl)-2-ylphenyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide results in increased expression of FLNB mRNA"29244179
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in increased expression of FLNB mRNA"25554681
D037742Nanotubes, Carbon"Nanotubes, Carbon results in increased expression of FLNB mRNA"25554681|2562005
C028007nickel monoxidenickel monoxide results in increased expression of FLNB mRNA19167457
C558013NSC 689534[NSC 689534 binds to Copper] which results in increased expression of FLNB mRNA20971185
C558013NSC 689534NSC 689534 results in increased expression of FLNB mRNA20971185
D000073878Palm OilPalm Oil results in increased expression of FLNB mRNA18042831
C496932panobinostatpanobinostat results in increased expression of FLNB mRNA26272509
C027579periodate-oxidized adenosineperiodate-oxidized adenosine affects the expression of FLNB mRNA17097637
D010634PhenobarbitalPhenobarbital results in decreased expression of FLNB mRNA23091169
D010662Phenylmercuric Acetate"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLNB mRNA"27188386
D010662Phenylmercuric AcetatePhenylmercuric Acetate results in increased expression of FLNB mRNA26272509
D010894PiroxicamPiroxicam results in decreased expression of FLNB mRNA21858171
D011078Polychlorinated BiphenylsPolychlorinated Biphenyls affects the expression of FLNB mRNA21334430
C513428pyrachlostrobinpyrachlostrobin results in increased expression of FLNB mRNA27029645
D011794QuercetinQuercetin results in increased expression of FLNB mRNA21632981
D020849Raloxifene HydrochlorideESR2 protein affects the reaction [Raloxifene Hydrochloride results in decreased expression of FLNB mRNA]14699072
D020849Raloxifene HydrochlorideRaloxifene Hydrochloride affects the expression of FLNB mRNA14699072
D020849Raloxifene Hydrochloride[Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of FLNB mRNA19059307
C116926rofecoxibrofecoxib results in increased expression of FLNB mRNA17070997
D012822Silicon DioxideSilicon Dioxide analog affects the secretion of FLNB protein25895662
C009277sodium arsenatesodium arsenate results in increased expression of FLNB mRNA21795629
D012999SomanSoman results in increased expression of FLNB mRNA19281266
D013467SulindacSulindac results in increased expression of FLNB mRNA24136188
D013629TamoxifenTamoxifen affects the expression of FLNB mRNA14699072
D013629Tamoxifen[Tamoxifen co-treated with ESR2 protein] results in decreased expression of FLNB mRNA19059307
D013629TamoxifenTamoxifen results in increased expression of FLNB mRNA25123088
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of FLNB mRNA12377990
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of FLNB mRNA20159946|2629044
D013755Tetradecanoylphorbol Acetate[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of FLNB mRNA25613284
D014028Tobacco Smoke PollutionTobacco Smoke Pollution results in decreased expression of FLNB mRNA28065790
D014212TretinoinTretinoin results in increased expression of FLNB mRNA16012519|1743110
D014241TrichloroethyleneTrichloroethylene results in increased methylation of FLNB gene27618143
C012589trichostatin A"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLNB mRNA"27188386
C012589trichostatin Atrichostatin A affects the expression of FLNB mRNA28542535
C012589trichostatin Atrichostatin A results in increased expression of FLNB mRNA24935251
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLNB mRNA"27188386
D014635Valproic AcidValproic Acid results in increased expression of FLNB mRNA23179753|2438349
D014638VanadatesVanadates results in increased expression of FLNB mRNA22714537
C025643vinclozolinvinclozolin affects the expression of FLNB mRNA19015723
D024483Vitamin K 3Vitamin K 3 results in decreased expression of FLNB mRNA25270620

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0003723RNA binding-HDA22681889  
GO:0003779actin binding-NAS8327473  
GO:0005515protein binding-IPI9437013  10644691  10676904  12393796  12577067  16076904  
17474147  19270716  
GO:0042802identical protein binding-IPI12393796  
GO:0045296cadherin binding-HDA25468996  
GO ID GO Term Qualifier Evidence PubMed
GO:0003334keratinocyte development-IEA-  
GO:0003382epithelial cell morphogenesis-IEA-  
GO:0007016cytoskeletal anchoring at plasma membrane-TAS9694715  
GO:0007165signal transduction-TAS8327473  
GO:0007519skeletal muscle tissue development-IEA-  
GO:0030036actin cytoskeleton organization-IEA-  
GO:0071346cellular response to interferon-gamma-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0001725stress fiber-IEA-  
GO:0005737cytoplasm-HDA16791210  
GO:0005829cytosol-IDA-  
GO:0005829cytosol-TAS-  
GO:0005886plasma membrane-IDA-  
GO:0005903brush border-IEA-  
GO:0005925focal adhesion-HDA21423176  
GO:0005938cell cortex-IEA-  
GO:0015629actin cytoskeleton-TAS9651345  
GO:0016021integral component of membrane-NAS8327473  
GO:0030018Z disc-IEA-  
GO:0045335phagocytic vesicle-IEA-  
GO:0070062extracellular exosome-HDA19056867  23533145  
KEGG ID KEGG Term
hsa04010MAPK signaling pathway
hsa04510Focal adhesion
Reactome ID Reactome Term Evidence
R-HSA-1169408ISG15 antiviral mechanismTAS
R-HSA-1169410Antiviral mechanism by IFN-stimulated genesTAS
R-HSA-1280215Cytokine Signaling in Immune systemTAS
R-HSA-168256Immune SystemTAS
R-HSA-913531Interferon SignalingTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal